Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50091, first published .
Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial

Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial

Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial

Luis Gajate   1 , MD, PhD ;   Inés de la Hoz   1 , MD ;   Mercedes Espiño   2 , MD, PhD ;   Maria del Carmen Martin Gonzalez   1 , MD ;   Cristina Fernandez Martin   1 , MD ;   Ascensión Martín-Grande   1 , MD ;   Diego Parise Roux   1 , MD ;   Oscar Pastor   3 , MD, PhD ;   Judith Villahoz   1 , MD ;   Miguel Ángel Rodriguez-Gandía   4 , MD, PhD ;   Javier Nuño Vazquez   5 , MD, PhD

1 Department of Anesthesiology and Critical Care, Instituto Ramon y Cajal de Investigacion Sanitaria, Hospital Universitario Ramon y Cajal, Madrid, Spain

2 Department of Immunology, Instituto Ramon y Cajal de Investigacion Sanitaria, Hospital Universitario Ramon y Cajal, Madrid, Spain

3 Department of Biochemistry, Instituto Ramon y Cajal de Investigacion Sanitaria, Hospital Universitario Ramon y Cajal, Madrid, Spain

4 Department of Digestive Diseases, Instituto Ramon y Cajal de Investigacion Sanitaria, Hospital Universitario Ramon y Cajal, Madrid, Spain

5 Department of Liver Surgery, Instituto Ramon y Cajal de Investigacion Sanitaria, Hospital Universitario Ramon y Cajal, Madrid, Spain

Corresponding Author:

  • Luis Gajate, MD, PhD
  • Department of Anesthesiology and Critical Care
  • Instituto Ramon y Cajal de Investigacion Sanitaria
  • Hospital Universitario Ramon y Cajal
  • Ctra de Colmenar Viejo Km 9,100
  • Madrid, 28034
  • Spain
  • Phone: 34 913368269
  • Email: gajate.luis@gmail.com